Use of Virtual Reality in Managing Emerging Infectious Diseases

The recent coronavirus (COVID-19) pandemic brought with it unprecedented health challenges and widespread economic disruption. However, it was also at the forefront of pushing innovative technologies and reshaping the way societies and industries operate. For instance, when students could not reach school, virtual classes brought education to them in their homes; remote work brought offices to workers; and telemedicine and teleconsultation offered crucial healthcare services for the sick and ailing. The pandemic also gave rise to innovations, such as COVID-19 tracking apps and drone deliveries, showcasing the adaptability of technology to current needs. Furthermore, it was seen as an opportunity to put to actual test and usage many prototype technologies. One such technology that saw advancement and usage during this difficult period was virtual reality (VR). Beyond its known application for entertainment and gaming, VR demonstrated its potential in contributing to the improvement of health and wellness. As per Bloomberg, the augmented reality (AR)/VR market is projected to achieve a staggering US$ 455 billion by the year 2030, marking a significant contrast to the 2020 statistics where the market valuation stood at a mere US$ 15 billion.